Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 100:3983-8.
Amelio I, Melino G. (2020). Context is everything: extrinsic signalling and gain-of- function p53 mutants. Cell Death Discov. 6:16.
Anderson CW, Bennett JJ. (2016). Clinical presentation and diagnosis of pancreatic neuroendocrine tumors. Surg. Oncol. Clin. N. Am. 25:363-374.
Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H. (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 449:1003-7.
Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 457:608-11.
Barker N, Bartfeld S, Clevers H. (2010). Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell Stem Cell. 7:656-70.
Barker N. (2014). Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 15:19-33.
Baylin SB, Weisburger WR, J Eggleston JC, Mendelsohn G, Beaven MA, Abeloff MD, Ettinger DS. (1978). Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications. N Engl J Med. 299:105-10.
Bennett DC, Peachey LA, Durbin H, Rudland PS. (1978). A possible mammary stem cell line. Cell. 5:283-98.
Biondi CA, Gartside MG, Waring P, Loffler KA, Stark MS, Magnuson MA, Kay GF, Hayward NK. (2004). Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Mol Cell Biol. 24:3125-31.
Bonnet D, Dick JE. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 3:730-7.
Burrell RA, McGranahan N, Bartek J, Swanton C. (2013). The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 501:338-45.
Chan CS, Laddha SV, Lewis PW, Koletsky MS, Robzyk K, Da Silva E, Torres PJ, Untch BR, Li J, Bose P, Chan TA, Klimstra DS, Allis CD, Tang LH. (2018). ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup. Nat Commun. 9:4158.
Chen C, Notkins AL, Lan MS. (2019). Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics. Mol Cancer Res. 17:1597- 1604.
Chiu CW, Nozawa H, Hanahan D. (2010). Survival benefit with proapoptotic molecular and pathologic responses from dual targeting of mammalian target of rapamycin and epidermal growth factor receptor in a preclinical model of pancreatic neuroendocrine carcinogenesis. J. Clin. Oncol. 28:4425-4433.
Choi S, Chen Z, Tang LH, Fang Y, Shin SJ, Panarelli NC, Chen YT, Li Y, Jiang X, Du YN. (2016). Bcl-xL promotes metastasis independent of its anti-apoptotic activity. Nat Commun. 7:10384.
Chun MG, Mao JH, Chiu CW, Balmain A, Hanahan D. (2010). Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis. Proc. Natl. Acad. Sci. USA. 107:17268-17273.
Cohnheim J. (1875). Congenitales, quergestreiftes Muskelsarkom der Nieren. Virchows Arch. 65: 64-69.
Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. (2005). Prospective identification of tumorigenic prostate cancer stem cells.Cancer Res. 65:10946-51.
Contractor T, Kobayashi S, da Silva E, Clausen R, Chan C, Vosburgh E, Tang LH, Levine AJ, Harris CR. (2016). Sexual dimorphism of liver metastasis by murine pancreatic neuroendocrine tumors is affected by expression of complement C5.Oncotarget. 7:30585-96.
de Lau W, Barker N, Low TY, Koo BK, Li VS, Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M, Stange DE, van Es JE, Guardavaccaro D, Schasfoort RB, Mohri Y, Nishimori K, Mohammed S, Heck AJ, Clevers H. (2011). Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling.Nature. 476:293-7.
Dick JE. (2008). Stem cell concepts renew cancer research. Blood. 112:4793-807.
Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, Zavidij O, Abel U, Arens A, Weichert W, Brand K, Koch M, Weitz J, Schmidt M, von Kalle C,Glimm H. (2011). Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell. 9:357-65.
Dorrell C, Tarlow B, Wang Y, Canaday PS, Haft A, Schug J, Streeter PR, Finegold MJ, Shenje LT, Kaestner KH, Grompe M. (2014). The organoid-initiating cells in mouse pancreas and liver are phenotypically and functionally similar. Stem Cell Res.13:275-83.
Du YC, Chou CK, Klimstra DS, Varmus H. (2011). Receptor for hyaluronan- mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis. Proc. Natl. Acad. Sci. USA.108:16753-16758.
Emmink BL, Van Houdt WJ, Vries RG, Hoogwater FJ, Govaert KM, Verheem A, Nijkamp MW, Steller EJ, Jimenez CR, Clevers H, Borel Rinkes IH, Kranenburg O. (2011). Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology. 141:269-78.
Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15:504-14.
Falchetti A. (2017). Genetics of multiple endocrine neoplasia type 1 syndrome: what’s new and what’s old. F1000Res. 6, F1000 Faculty Rev-73.
Franko J, Feng W, Yip L, Genovese E, Moser AJ. (2010). Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J. Gastrointest. Surg. 14:541-548.
Fujii E, Suzuki M, Matsubara K, Watanabe M, Chen YJ, Adachi K, Ohnishi Y, Tanigawa M, Tsuchiya M, Tamaoki N. (2008). Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse. Pathol Int.58:559-67.
Fumagalli A, Oost KC, Kester L, Morgner J, Bornes L, Bruens L, Spaargaren L, Azkanaz M, Schelfhorst T, Beerling E, Heinz MC, Postrach D, Seinstra D, Sieuwerts AM, Martens JWM, van der Elst S, van Baalen M, Bhowmick D, Vrisekoop N, Ellenbroek SIJ, Suijkerbuijk SJE, Snippert HJ, van Rheenen J. (2020). Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell Stem Cell. 26:569-578.e7.
Gierl MS, Karoulias N, Wende H, Strehle M, Birchmeier C. (2006). The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes Dev. 20:2465-78.
Goto Y, De Silva MG, Toscani A, Prabhakar BS, Notkins AL, Lan MS. (1992). A novel human insulinoma-associated cDNA, IA-1, encodes a protein with ""zinc-finger"" DNA-binding motifs. J Biol Chem. 267:15252-7.
Grant SG, Seidman I, Hanahan D, Bautch VL. (1991) Early invasiveness characterizes metastatic carcinoid tumors in transgenic mice. Cancer Res. 51:4917- 4923.
Greaves M, Maley CC. (2012). Clonal evolution in cancer. Nature. 481:306-13.
Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, Lander ES. (2011). Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell. 146:633-44.
Hager JC, Fligiel S, Stanley W, Richardson AM, Heppner GH. (1981). Characterization of a variant-producing tumor cell line from a heterogeneous strain BALB/cfC3H mouse mammary tumor. Cancer Res. 41:1293-1300.
Hanahan D. (1985). Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 315:115–122.
Hanahan D, Weinberg RA. (2011). Hallmarks of cancer: the next generation. Cell. 144:646-64.
Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 1:313-23.
Jacques TS, Swales A, Brzozowski MJ, Henriquez NV, Linehan JM, Mirzadeh Z, O' Malley C, Naumann H, Alvarez-Buylla A, Brandner S. (2010). Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J. 29:222-35.
Jung YS, Park JI. (2020). Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond beta-catenin and the destruction complex. Exp Mol Med. 52:183-191.
Junttila MR, de Sauvage FJ. (2013). Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 501:346-54.
Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z. (2008). GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell. 13:141-52.
Kremer L, Márquez G. (2004). Generation of monoclonal antibodies against chemokine receptors. Methods Mol Biol. 239:243-60.
Kreso A, Dick JE. (2014). Evolution of the cancer stem cell model. Cell Stem Cell. 14:275-91.
Kuo EJ, Salem RR. (2013). Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann. Surg. Oncol. 20:2815–2821.
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 367:645-8.
Lawson DA, Bhakta NR, Kessenbrock K, Prummel KD, Yu Y, Takai K, Zhou A, Eyob H, Balakrishnan S, Wang CY, Yaswen P, Goga A, Werb Z. (2015). Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature.2015 526:131-5.
Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. (2007). Identification of pancreatic cancer stem cells. Cancer Res.67:1030-7.
Liu JC, Voisin V, Wang S, Wang DY, Jones RA, Datti A, Uehling D, Al-awar R, Egan SE, Bader GD, Tsao M, Mak TW, Zacksenhaus E. (2014). Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K. EMBO Mol Med. 6:1542-60.
Lopez T, Hanahan D. (2002). Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. 1:339–353.
Ma Z, Guo D, Wang Q, Liu P, Xiao Y, Wu P, Wang Y, Chen B, Liu Z, Liu Q. (2019). Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma. Theranostics. 9:2967-2983.
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704-15.
Meacham CE, Morrison SJ. (2013). Tumour heterogeneity and cancer cell plasticity. Nature. 501:328-37.
Nguyen LV, Vanner R, Dirks P, Eaves CJ. (2012). Cancer stem cells: an evolving concept. Nat Rev Cancer. 12:133-43.
O'Brien CA, Pollett A, Gallinger S, Dick JE. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 445:106-10.
Olson P, Chu GC, Perry SR, Nolan-Stevaux O, Hanahan D. (2011). Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma. Proc. Natl. Acad. Sci. USA.108:E1275-E1284.
Osipovich AB, Long Q, Manduchi E, Gangula R, Hipkens SB, Schneider J, Okubo T, Stoeckert CJ Jr, Takada S, Magnuson MA. (2014). Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3. Development. 141:2939-49.
Pak JN, Jung JH, Park JE, Hwang J, Lee HJ, Shim BS, Kim SH. (2020). p53 dependent LGR5 inhibition and caspase 3 activation are critically involved in apoptotic effect of compound K and its combination therapy potential in HCT116 cells. Phytother Res. 34:2745-2755.
Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. (2006). Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 25:1696-708.
Pierce GB Jr, Dixon FJ Jr, Verney EL. (1960). Teratocarcinogenic and tissue- forming potentials of the cell types comprising neoplastic embryoid bodies Lab. Invest. 9:583-602.
Pierce GB, Cox WF. (1978). Neoplasms as caricatures of tissue renewal. Cell differentiation and neoplasia, Rave Press, New York. 1996-2004.
Pierce GB, Speers WC. (1988). Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res. 48:1996-2004.
Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, Squire JA, Smith A, Dirks P. (2009). Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 4:568-80.
Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE. (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 104:973-8.
Pyonteck SM, Gadea BB, Wang HW, Gocheva V, Hunter KE, Tang LH, Joyce JA. (2012). Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development. Oncogene. 31:1459-67.
Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM, Morrison SJ. (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell. 18:510-23.
Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P. (2011). Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 364:501-13.
Reya T, Clevers H. (2005). Wnt signalling in stem cells and cancer. Nature. 434:843- 50.
Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature. 445:111-5.
Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M. (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 141:583-94.
Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y. (1986). The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol. 125:431-5.
Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, Weinberg RA. (2011). Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell. 145:926-40.
Sennino B, Ishiguro-Oonuma T, Schriver BJ, Christensen JG, McDonald DM. (2013).Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice. Cancer Res. 73:3692–3703.
Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, Wong KK, Brandstetter K, Wittner B, Ramaswamy S, Classon M, Settleman J. (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell. 141:69-80.
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. (2004). Identification of human brain tumour initiating cells. Nature. 432:396-401.
Suzuki M, Katsuyama K, Adachi K, Ogawa Y, Yorozu K, Fujii E, Misawa Y, Sugimoto T. (2002). Combination of fixation using PLP fixative and embedding in paraffin by the AMeX method is useful for histochemical studies in assessment of immunotoxicity. J Toxicol Sci. 27:165-72.
Takahashi K, Yamanaka S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663-676.
Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, Ikeda M, Yokobori T, Mimori K, Yamamoto H, Sekimoto M, Doki Y, Mori M. (2011). Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol. 18:1166-74.
Takeda K, Kinoshita I, Shimizu Y, Matsuno Y, Shichinohe T, Dosaka-Akita H. (2011). Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res. 31:263-70.
Takeda N, Jain R, LeBoeuf MR, Wang Q, Lu MM, Epstein JA. (2011). Interconversion between intestinal stem cell populations in distinct niches. Science. 334:1420-4.
Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD, de Sauvage FJ. (2011). A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 478:255-9.
Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, Stassi G. (2007). Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell. 1:389-402.
Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, Richel DJ, Stassi G, Medema JP. (2008). Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A.105:13427-32.
Vermeulen L, De Sousa E Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP. (2010). Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 12:468-76.
Wang Y, Jing Y, Ding L, Zhang X, Song Y, Chen S, Zhao X, Huang X, Pu Y, Wang Z, Ni Y, Hu Q. (2019). Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway. J Exp Clin Cancer Res. 38:274.
Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ, Whittaker CA, Hoersch S, Yoon S, Crowley D, Bronson RT, Chiang DY, Meyerson M, Jacks T. (2011). Suppression of lung adenocarcinoma progression by Nkx2-1. Nature. 473:101-4.
Wiwatpanit T, Lorenzen SM, Cantú JA, Foo CZ, Hogan AK, Márquez F, Clancy JC, Schipma MJ, Cheatham MA, Duggan A, García-Añoveros J. (2018). Trans- differentiation of outer hair cells into inner hair cells in the absence of INSM1. Nature. 563:691-695.
Wu C, Wei Q, Utomo V, Nadesan P, Whetstone H, Kandel R, Wunder JS, Alman BA. (2007). Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res. 67:8216-22.
Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K. (2011). Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 364:514-23.
Zhang T, Wang H, Saunee NA, Breslin MB, Lan MS. (2010). Insulinoma-associated antigen-1 zinc-finger transcription factor promotes pancreatic duct cell trans- differentiation. Endocrinology. 151:2030-2039.
Zhang T, Saunee NA, Breslin MB, Song K, Lan MS. (2012). Functional role of an islet transcription factor, INSM1/IA-1, on pancreatic acinar cell trans-differentiation. J Cell Physiol. 227:2470-9.
Zhong Z, Virshup DM. (2020). Wnt Signaling and Drug Resistance in Cancer. Mol Pharmacol. 97:72-89.
論文の公開元へ
